Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs irbesartan for blood pressure control in hemodialysis patients
2004-004865-14Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of valsartan and irbesartan in hypertension (HTN) (2 arms), sponsored by Novartis. Primary endpoint: Predialytic mean sitting systolic blood pressure after 4 weeks. Started Feb 2005; status: completed.
02
Drugs
valsartanirbesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2004-004865-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004865-14.